Marina Bay Sands' VIP gaming yields finally rebound

Its rolling chip volume grew 32% after a 5-quarter drop.

Lady Luck was smiling on Marina Bay Sands in the past quarter as its VIP segment struck a rebound, with rolling chip volume (RCV) recording a 32% growth after the downtrend in the past five quarters.

According to UOB Kay Hian flash report, Marina Bay Sands’ (MBS) core adjusted earnings before interest, tax, depreciation and amortization (EBITDA) rose 37.8% yoy to US$492m, thanks to luck factor and recovery in VIP gaming volume.

Meanwhile, its mass market has yet to see its lucky card as gross gaming revenues (GGR) grew by only around 1%.

"On a yoy basis, non-rolling volume stayed flat with mass table GGR easing close to 1%, but this was offset by improved slot volume and slot GGR (+7% and +3% respectively). MBS’ mass market segment GGR’s yoy growth hovered in the range of +/-1% in 4Q16-2Q17," UOB Kay Hian said.
 

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare